ATE454444T1 - Verfahren zur herstellung rekombinanter proteine - Google Patents

Verfahren zur herstellung rekombinanter proteine

Info

Publication number
ATE454444T1
ATE454444T1 AT04768294T AT04768294T ATE454444T1 AT E454444 T1 ATE454444 T1 AT E454444T1 AT 04768294 T AT04768294 T AT 04768294T AT 04768294 T AT04768294 T AT 04768294T AT E454444 T1 ATE454444 T1 AT E454444T1
Authority
AT
Austria
Prior art keywords
recombinant protein
coli host
periplasm
growth rate
host cell
Prior art date
Application number
AT04768294T
Other languages
English (en)
Inventor
David John Glover
Mukesh Sehdev
Dominic Gambier Reeks
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29226759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE454444(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Application granted granted Critical
Publication of ATE454444T1 publication Critical patent/ATE454444T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
AT04768294T 2003-09-09 2004-09-02 Verfahren zur herstellung rekombinanter proteine ATE454444T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321100.0A GB0321100D0 (en) 2003-09-09 2003-09-09 Biological products
PCT/GB2004/003747 WO2005024000A1 (en) 2003-09-09 2004-09-02 Methods for producing recombinant proteins

Publications (1)

Publication Number Publication Date
ATE454444T1 true ATE454444T1 (de) 2010-01-15

Family

ID=29226759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768294T ATE454444T1 (de) 2003-09-09 2004-09-02 Verfahren zur herstellung rekombinanter proteine

Country Status (20)

Country Link
US (2) USRE44512E1 (de)
EP (1) EP1664278B1 (de)
JP (1) JP4568722B2 (de)
KR (1) KR20060125704A (de)
CN (1) CN1849389B (de)
AT (1) ATE454444T1 (de)
AU (1) AU2004270929B2 (de)
BR (1) BRPI0413813A (de)
CA (1) CA2536099C (de)
DE (1) DE602004025011D1 (de)
EA (1) EA200600554A1 (de)
ES (1) ES2339352T3 (de)
GB (1) GB0321100D0 (de)
IL (1) IL173474A0 (de)
MX (1) MXPA06002589A (de)
NO (1) NO20061576L (de)
PL (1) PL1664278T3 (de)
SG (1) SG145696A1 (de)
WO (1) WO2005024000A1 (de)
ZA (1) ZA200601177B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE515566T1 (de) * 2005-05-26 2011-07-15 Cytos Biotechnology Ag Skalierbares fermentationsverfahren
CN104928336B (zh) 2009-10-26 2020-05-08 弗·哈夫曼-拉罗切有限公司 用于生产糖基化免疫球蛋白的方法
JP6362543B2 (ja) 2012-02-23 2018-07-25 ジュノ セラピューティクス ゲーエムベーハー 細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
CN108410788A (zh) * 2012-03-12 2018-08-17 韩美科学株式会社 高密度培养大肠杆菌细胞的方法
HK1249847A1 (zh) 2015-03-09 2018-11-16 Intekrin Therapeutics, Inc. 用於治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法
CN108474791B (zh) 2015-10-22 2022-07-08 朱诺治疗学有限公司 培养细胞的方法及用于该方法的试剂盒和设备
HK1258932A1 (zh) 2015-10-22 2019-11-22 Juno Therapeutics Gmbh 用於转导的方法、反应剂盒、反应剂和设备
CN109312299A (zh) 2016-03-29 2019-02-05 格尔托公司 蛋白质在具有0.5:1至10:1的周质体积与细胞质体积比的革兰氏阴性菌中的表达
KR20200036808A (ko) 2017-04-03 2020-04-07 코히러스 바이오사이언시스, 인크. 진행성 핵상 마비 치료를 위한 PPARγ 작용제
MA49288A (fr) 2017-04-27 2020-03-04 Juno Therapeutics Gmbh Reactifs particulaires oligomères et leurs méthodes d'utilisation
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
EP3874024A1 (de) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Verfahren zur selektion und stimulation von zellen und vorrichtung dafür
US20200207812A1 (en) 2018-12-07 2020-07-02 Coherus Biosciences, Inc. Methods for producing recombinant proteins
TW202104254A (zh) 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
WO2021072182A1 (en) 2019-10-11 2021-04-15 Coherus Biosciences, Inc. Methods for producing ranibizumab
US20240092883A1 (en) 2019-10-11 2024-03-21 Coherus Biosciences, Inc. Methods of purifying ranibizumab or a ranibizumab variant
CN113355264B (zh) * 2021-06-28 2022-03-08 山东智汇达海洋生物科技有限公司 一株产甘油的嗜高温菌及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335567A3 (de) 1988-03-30 1990-11-14 Biogen, Inc. Kontrollierte Freisetzung periplasmatischer Proteine in das Medium
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
CA2090126C (en) 1990-08-02 2002-10-22 John W. Schrader Methods for the production of proteins with a desired function
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
CA2426100A1 (en) * 2000-11-03 2002-05-23 Genentech, Inc. Metabolic rate shifts in fermentations expressing recombinant proteins
ATE353969T1 (de) 2003-08-13 2007-03-15 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide

Also Published As

Publication number Publication date
EP1664278A1 (de) 2006-06-07
AU2004270929B2 (en) 2010-01-21
NO20061576L (no) 2006-04-07
JP2007504815A (ja) 2007-03-08
EA200600554A1 (ru) 2006-08-25
WO2005024000A1 (en) 2005-03-17
DE602004025011D1 (de) 2010-02-25
SG145696A1 (en) 2008-09-29
CA2536099C (en) 2015-11-17
EP1664278B1 (de) 2010-01-06
AU2004270929A1 (en) 2005-03-17
CN1849389B (zh) 2012-05-23
BRPI0413813A (pt) 2006-10-17
ES2339352T3 (es) 2010-05-19
KR20060125704A (ko) 2006-12-06
GB0321100D0 (en) 2003-10-08
IL173474A0 (en) 2006-06-11
USRE44512E1 (en) 2013-10-01
US7754447B2 (en) 2010-07-13
PL1664278T3 (pl) 2010-06-30
CN1849389A (zh) 2006-10-18
MXPA06002589A (es) 2006-06-05
ZA200601177B (en) 2007-04-25
CA2536099A1 (en) 2005-03-17
JP4568722B2 (ja) 2010-10-27
US20080044817A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
DE602004025011D1 (de) Verfahren zur herstellung rekombinanter proteine
WO2023049742A3 (en) Engineered casx repressor systems
CY1110494T1 (el) Μεταστροφες μεταβολικου ρυθμου σε ζυμωσεις που εκφραζουν ανασυνδυασμενες πρωτεϊνες
ATE415471T1 (de) Verfahren zur reklonierung von produktionszellen
DE602004019304D1 (de) Genexpressionsmethode
PL376381A1 (en) Methods and media for controlling sialylation of proteins produced by mammalian cells
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
WO2002099067A3 (en) Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
ATE317897T1 (de) System und methode zur herstellung von rekombinanten, glykosylierten protein in prokaryontischen wirtszellen
ATE486935T1 (de) Mikroorganismenstamm zur produktion von rekombinanten proteinen
GB2429211A (en) Feeder independent extended culture of embryonic stem cells
Viader‐Salvadó et al. Shrimp (Litopenaeus vannamei) trypsinogen production in Pichia pastoris bioreactor cultures
ATE493503T1 (de) Verfahren zur fermentativen herstellung von proteinen
ATE312939T1 (de) Verfahren zur rekombinanten herstellung von polypeptiden
ATE358681T1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
DE60335602D1 (de) Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
CN102286518B (zh) 构建严谨型t7表达系统宿主菌的方法
RU2008112882A (ru) Новая система селекции
WO2004046359A3 (en) Method of controlling gene expression in plants or plant cells
SE9904247D0 (sv) Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast
MX2023015460A (es) Celula huesped de bacillus mejorada con proteina rema/remb alterada.
Dragosits The interrelation of environmental factors and heterologous protein production in Pichia pastoris: a systems biology approach
Donpromma et al. Production of recombinant bone morphogenetic protein‐2 in Escherichia coli: process optimization in shake flask and bioreactor cultures using statistical experimental design
CN122038152A (zh) 一种多维协同调控的产重组人血清白蛋白的酿酒酵母工程菌及其构建方法与应用
DE602004029868D1 (de) Verfahren zur herstellung eines heterologen proteins in e. coli

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties